Quick Answer
BeOne Medicines Ltd. reported Earnings Per Share Diluted of $0.19 per share for the year ending 2025.
- BeOne Medicines Ltd. showed an increase of +140.4% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from BeOne Medicines Ltd.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), BeOne Medicines Ltd.'s Earnings Per Share Diluted has grown by 115.6%.
- Historical annual values: Fiscal year 2025: $0.19 per share | Fiscal year 2024: $0.47 (loss) per share | Fiscal year 2023: $0.65 (loss) per share | Fiscal year 2022: $1.49 (loss) per share | Fiscal year 2021: $1.21 (loss) per share | Fiscal year 2020: $1.50 (loss) per share | Fiscal year 2019: $1.22 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: